SchooLinks Recognized Among America's Best Startup Employers by Forbes and Inc.
08 mai 2024 07h15 HE
|
SchooLinks
Austin, TX, May 08, 2024 (GLOBE NEWSWIRE) -- SchooLinks, the most innovative platform for college and career readiness, is proud to announce its recent achievements in both business growth and...
DIAGNOS présentera des solutions d'IA de pointe pour la santé rétinienne à ARVO 2024
06 mai 2024 09h00 HE
|
DIAGNOS inc.
BROSSARD, Québec, 06 mai 2024 (GLOBE NEWSWIRE) -- Diagnos inc. (« DIAGNOS » ou la « Société ») (Bourse de croissance TSX : ADK) (OTCQB : DGNOF), un pionnier dans le dépistage précoce de...
DIAGNOS to Present Cutting-Edge AI Solutions for Retinal Health at ARVO 2024
06 mai 2024 09h00 HE
|
DIAGNOS Inc.
BROSSARD, Quebec, May 06, 2024 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or “the Company”) (TSX Venture: ADK) (OTCQB: DGNOF), a provider of healthcare services in early detection of certain...
DIAGNOS accélérera la demande de licence d'instrument médical à Santé Canada et à la FDA des États-Unis concernant ses 4 nouveaux modules d'analyse, et prévoit la certification ISO 27001
16 avr. 2024 11h08 HE
|
DIAGNOS inc.
BROSSARD, Québec, 16 avr. 2024 (GLOBE NEWSWIRE) -- Diagnos Inc. (« DIAGNOS » ou « la Société ») (Bourse de croissance TSX : ADK) (OTCQB : DGNOF), un fournisseur de services de soins de santé en...
DIAGNOS to expedite application for Medical Device License to Health Canada and US FDA related to its 4 new analysis modules, and is planning ISO 27001 certification
16 avr. 2024 11h08 HE
|
DIAGNOS Inc.
BROSSARD, Quebec, April 16, 2024 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or “the Company”) (TSX Venture: ADK) (OTCQB: DGNOF), a provider of healthcare services in early detection of certain...
Inc.’s 2024 Female Founders list highlights why female founders are always a good bet
09 avr. 2024 12h19 HE
|
Adyn, Inc.
Inc’s 2024 Female Founders list highlights why female founders are always a good bet. adyn founder, Elizabeth Ruzzo, is named to the list.
DIAGNOS inc. présentera à la conférence des investisseurs hybrides AI & Technologie le 11 avril
09 avr. 2024 10h10 HE
|
DIAGNOS inc.
MONTRÉAL, 09 avr. 2024 (GLOBE NEWSWIRE) -- DIAGNOS inc. (ADK TSX : OTCQB : DGNOF)), basée à Montréal, au Canada, spécialisée dans l'intelligence artificielle pour le marché médical, a annoncé...
DIAGNOS Inc. to Present at the AI & Technology Hybrid Investor Conference April 11th
09 avr. 2024 10h10 HE
|
DIAGNOS Inc.
MONTREAL, April 09, 2024 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (ADK TSX: OTCQB: DGNOF), based in Montreal, Canada, focused on Artificial Intelligence for the medical market, today announced that André...
DIAGNOS inc. to Present at the AI & Technology Hybrid Investor Conference April 11th
09 avr. 2024 08h35 HE
|
Virtual Investor Conferences
MONTREAL, April 09, 2024 (GLOBE NEWSWIRE) -- DIAGNOS inc. (ADK TSX: OTCQB: DGNOF), based in Montreal, Canada, focused on Artificial Intelligence for the medical market, today announced that Andre...
DIAGNOS Announces Grant of Stock Options
03 avr. 2024 14h13 HE
|
DIAGNOS Inc.
BROSSARD, Quebec, April 03, 2024 (GLOBE NEWSWIRE) -- Diagnos Inc. ("DIAGNOS" or the "Corporation") (TSX Venture: ADK) (OTCQB: DGNOF), a pioneer in early detection of critical health issues through...